Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 21/07/19971 min de lecture
Oral Dosage Form New Animal Drugs; Enrofloxacin Tablets
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer Corp., Agriculture Division, Animal Health. The supplemental NADA provides for revised conditions for use (dose, indications, and limitations) of enrofloxacin tablets in dogs and cats for the management of diseases associated with bacteria susceptible to enrofloxacin.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →